149 related articles for article (PubMed ID: 14597213)
1. Fas Ligand-dependent and -independent mechanisms of toxicity induced by T cell lymphomas in lymphoid organs and in the liver.
Lombard C; McKallip RJ; Hylemon PB; Nagarkatti PS; Nagarkatti M
Clin Immunol; 2003 Nov; 109(2):144-53. PubMed ID: 14597213
[TBL] [Abstract][Full Text] [Related]
2. Growth of FasL-bearing tumor cells in syngeneic murine host induces apoptosis and toxicity in Fas(+) organs.
Zeytun A; Nagarkatti M; Nagarkatti PS
Blood; 2000 Mar; 95(6):2111-7. PubMed ID: 10706882
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived Fas ligand induces toxicity in lymphoid organs and plays an important role in successful chemotherapy.
Nagarkatti N
Cancer Immunol Immunother; 2000 Apr; 49(1):46-55. PubMed ID: 10782865
[TBL] [Abstract][Full Text] [Related]
4. Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo.
Do Y; Ryu S; Nagarkatti M; Nagarkatti PS
Toxicol Sci; 2002 Nov; 70(1):63-72. PubMed ID: 12388836
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity exhibited by Fas ligand (CD95L) overexpressed on lymphoid cells against Fas+ tumor cells.
Shimizu M; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
Cancer Immunol Immunother; 1998 Nov; 47(3):143-8. PubMed ID: 9829839
[TBL] [Abstract][Full Text] [Related]
6. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
[TBL] [Abstract][Full Text] [Related]
7. Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice.
Kremer L; Estaquier J; Wolowczuk I; Biet F; Ameisen JC; Locht C
Infect Immun; 2000 Jul; 68(7):4264-73. PubMed ID: 10858244
[TBL] [Abstract][Full Text] [Related]
8. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome.
Bonardelle D; Bobé P; Reynès M; Amouroux J; Tricottet V; Godeau F; Kiger N
J Rheumatol; 2001 May; 28(5):956-61. PubMed ID: 11361222
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
11. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
12. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
[TBL] [Abstract][Full Text] [Related]
13. Fas-Fas ligand-based interactions between tumor cells and tumor-specific cytotoxic T lymphocytes: a lethal two-way street.
Zeytun A; Hassuneh M; Nagarkatti M; Nagarkatti PS
Blood; 1997 Sep; 90(5):1952-9. PubMed ID: 9292529
[TBL] [Abstract][Full Text] [Related]
14. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
16. Targeting dendritic cells with CD44 monoclonal antibodies selectively inhibits the proliferation of naive CD4+ T-helper cells by induction of FAS-independent T-cell apoptosis.
Termeer C; Averbeck M; Hara H; Eibel H; Herrlich P; Sleeman J; Simon JC
Immunology; 2003 May; 109(1):32-40. PubMed ID: 12709015
[TBL] [Abstract][Full Text] [Related]
17. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
[TBL] [Abstract][Full Text] [Related]
18. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
19. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces Fas-dependent activation-induced cell death in superantigen-primed T cells.
Camacho IA; Nagarkatti M; Nagarkatti PS
Arch Toxicol; 2002 Oct; 76(10):570-80. PubMed ID: 12373453
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T cells reactivated with superantigen are both more sensitive to FasL-mediated killing and express a higher level of FasL.
Wang JK; Zhu B; Ju ST; Tschopp J; Marshak-Rothstein A
Cell Immunol; 1997 Aug; 179(2):153-64. PubMed ID: 9268499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
